Atlas Trials

Study of Safety and Efficacy of C-CAR011 in B-NHL Patients

Clinical trial NCT03154775 · UNKNOWN

Trial details

NCT number
NCT03154775
Sponsor
Shanghai AbelZeta Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Refractory or Relapsed Non-Hodgkin Lymphoma
Start date
2017-05-03
Primary completion
2018-04-30
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.